The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
13hon MSNOpinion
RFK Jr.’s Miasma Theory of Health Is Spreading
The NIH is picking up Robert F. Kennedy Jr.’s argument that a healthy immune system can keep even pandemic germs at bay.
WHO emphasizes integrating surveillance into national STI programs. Zoliflodacin, a novel antimicrobial agent, shows promise in treating gonorrhea, demonstrating non-inferiority to ...
Calls are growing for legal reforms to outlaw the use of Maslaha in sexual violence cases and strengthen community awareness.
The clothing selection defies what you might expect from a secondhand shop. Designer labels mingle with vintage treasures and everyday basics, creating a democratic fashion experience where a $5 ...
AllAfrica on MSN
Uganda: Transcript and Audio | November 18 Digital Press Briefing On Lenacapavir Delivery and the America First Global Health Strategy
Good morning and welcome, everyone, to today's press briefing from the U.S. Department of State's Africa Media Hub. Today, we are discussing the America First Global Health Strategy and the U.S.
A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results